NIH-funded research NIH-funded research

Understanding Genetic Changes in Liver Cells and Chronic Liver Disease

Official title: Elucidating chronic liver disease pathways using somatic genetics

Funded at Ut Southwestern Medical Center · NIH-11184312 · Data updated 2026-11-12

This project explores how small genetic changes that naturally happen in our liver cells might influence chronic liver disease and its progression.

More Chronic Liver Disease research and trials

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUt Southwestern Medical Center
NIH-funded
Lab location1 site (Dallas, United States)
Project startSeptember 15, 2024
Project endJune 30, 2029
Funding year2025
Award (this year)$754,400
NIH project number5DP1DK139976-02
Project IDNIH-11184312 on NIH RePORTER

Who could benefit from this research

Could help

Patients with chronic liver disease, particularly those at risk of or experiencing progression to cirrhosis, could benefit from future treatments developed from this fundamental understanding.

Less likely to help

Patients without chronic liver disease or those whose condition is not related to the genetic mechanisms being studied may not directly benefit from this specific research.

What this research studies

Chronic liver disease is a widespread condition, and we currently lack effective treatments to slow its progression to severe scarring, known as cirrhosis. This research focuses on the idea that our body tissues, including the liver, gather many small genetic changes, called somatic mutations, over time and with injury. Scientists believe these mutations could offer clues into how liver disease develops and worsens. The project uses advanced genetic screening methods to find out which of these mutations have the biggest impact, with some early findings suggesting certain mutations might even help the liver regenerate or prevent metabolic disease. The goal is to discover if cells can select for mutations that actually improve, rather than worsen, conditions like fatty liver disease or cancer.

Why it matters

Potential benefit: If successful, this work could lead to new therapies that slow or stop the progression of chronic liver disease to cirrhosis by targeting specific genetic changes.

How similar studies have gone: While the concept of somatic mutations is known, the idea that some mutations might ameliorate disease and the high-throughput genetic screens used here represent a novel and relatively untested approach in this specific context.

Where this research is happening

  • Ut Southwestern Medical Center
    Dallas, United States
    Active

Researchers

  • Principal investigator: Zhu, Hao — Ut Southwestern Medical Center
  • Study coordinator: Zhu, Hao

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.